Thymalin/Thymulin

Name:  Lynn
Wechat：  15914422644

Tel：+86  15914422644

Whatsapp: +852 6252 8290

Email：    guangsheng 5   @zgguangsheng.com

I. Core Structure & Properties

II. Mechanism of Action

1. T-Cell Differentiation: Drives intrathymic maturation of T-cell progenitors, induces CD3/TCR expression, and promotes naive-to-effector T-cell transition.
2. Immune Modulation: Enhances T-cell cytotoxicity, suppressor function, IL-2 secretion, and NK cell activity; balances pro-/anti-inflammatory cytokine profiles (e.g., reduces TNF-α, increases IL-10).
3. Neuroendocrine Crosstalk: Bidirectional signaling with the hypothalamic–pituitary axis; follows circadian rhythms; ACTH/ cortisol and thyroid hormones regulate its secretion, while thymulin modulates pituitary hormone release.
4. Zinc-Driven Conformation: Zn²⁺ binding stabilizes the active tertiary structure required for receptor interaction and pore formation in target cell membranes.

III. Biological Roles & Research Applications

Physiological Functions

• Immune Homeostasis: Critical for postnatal T-cell repertoire development; declines with age (undetectable in humans >60 years).
• Inflammation Control: Mitigates excessive proinflammatory responses in sepsis, autoimmunity, and neuroinflammation.
• Neuroendocrine Link: Regulates stress responses via ACTH–thymulin feedback loops; influences circadian immune rhythms.

Research Uses

1. Immunology: Probe T-cell development, thymus–neuroendocrine axis, and age-related immunosenescence.
2. Therapeutic Models: Test in autoimmune diseases (e.g., lupus, MS), immunodeficiencies, sepsis, and cancer (adjuvant to immunotherapy).
3. Peptide Engineering: Develop Zn-stabilized analogs (e.g., metFTS) for enhanced half-life and oral bioavailability.
4. Diagnostics: Measure active Zn–thymulin levels to assess thymic endocrine function in immunocompromised patients.

IV. Research Protocols & Safety

1. Dosing Guidelines: Preclinical in vivo: 0.1–1 mg/kg (IP/IV) 2–3× weekly; in vitro: 10–100 nM for cell culture assays.
2. Handling: Reconstitute with sterile Zn²⁺-supplemented saline (50–100 μM ZnCl₂) to preserve activity; discard reconstituted solution after 48 hours.
3. Safety: Low toxicity in preclinical models; potential risks include transient immunosuppression at high doses and Zn imbalance. Use standard PPE; dispose of waste per biological safety regulations.